| Literature DB >> 31656197 |
Marianna Vitaloni1, Angie Botto-van Bemden2, Rosa Maya Sciortino Contreras3, Deborah Scotton4, Marco Bibas5, Maritza Quintero3, Jordi Monfort6, Xavier Carné7, Francisco de Abajo8, Elizabeth Oswald5, Maria R Cabot9, Marco Matucci10, Patrick du Souich11, Ingrid Möller12, Guy Eakin4, Josep Verges5.
Abstract
BACKGROUND: Knee osteoarthritis (KOA) is a prevalent form of chronic joint disease associated with functional restrictions and pain. Activity limitations negatively impact social connectedness and psychological well-being, reducing the quality of life (QoL) of patients. The purpose of this review is to summarize the existing information on QoL in KOA patients and share the reported individual factors, which may influence it.Entities:
Keywords: Individual factors; Knee; Osteoarthritis; Patient Centred; Patient advocacy organizations; Psychosocial factors; Quality of life; Social Determinants of Health
Mesh:
Year: 2019 PMID: 31656197 PMCID: PMC6815415 DOI: 10.1186/s12891-019-2895-3
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Quality Appraisal tool. The quality appraisal tool is a modify version of the quality appraisal tool recommended by Cochrane. Three independent researchers scored the 13 items
Fig. 2Flowchart of study selection. A total of 9143 articles were initially identify, 610 articles were then selected based on title and abstract screening. 62 articles were included in the final study
Overview of studies reporting QoL in patients with KOA
| References | Country | Study design | QoL instrument | Total Sample Size | Control Population | KOA Patients | Mean age | Gender Distribution |
|---|---|---|---|---|---|---|---|---|
| Cuzdan, 2017 [ | Turkey | Cross-Sectional | SF-36 | 85 | 25 | 60 | 65.79 | Knee OA: 57 female; 3 male |
| Control: 13 female; 12 male | ||||||||
| Elbaz, 2017 [ | Israel | Prospective observational | SF-36 | 93 | 30 | 63 | 64.2 | Knee OA: 41 female; 22 male |
| Control: 9 female; 21 male | ||||||||
| Lee, 2017 [ | USA | Cross-Sectional | SF-36 | 120 | 40 | 80 | 60.3 | Knee OA: 61 female; 19 male |
| Control: NA | ||||||||
| Rundell, 2017 [ | USA | Prospective | EQ-5D | 5155 | 4711 | 368 | 75.3 | Knee OA: 272 female; 96 male |
| Control 3017 female; 1694 male | ||||||||
| Wright, 2017 [ | Australia | Cross-Sectional | SF-36 | 120 | 40 | 80 | 64 | Knee OA: 44 female; 36 male |
| Araujo, 2016 [ | Brazil | Cross-Sectional | SF-12 | 93 | 93 | 60 | Knee OA: 69 female; 24 male Control: 24 female; 16 male | |
| Bokaeian, 2016 [ | Iran | Randomized clinical trial | WOMAC | 28 | 28 | 52.9 | Knee OA: 25 female; 2 male | |
| Cho, 2016 [ | Republic of Korea | Prospective cohort study | SF-36 | 681 | 71.9 | Knee OA: 383 female; 298 male | ||
| Kaban, 2016 [ | Turkey | Cross-Sectional | SF-36 | 63 | 21 | 42 | 56.86 | All female |
| Gomes-Neto, 2016 [ | Brazil | Cross-Sectional | SF-36 | 35 | 35 | 66.57 | Knee OA: 29 female; 6 male | |
| Khatib, 2016 [ | Australia | Cross-Sectional | Tot. EQ (adjusted from EQ-5D-5L) | 2809 | 2809 | 68 | Knee OA: 1740 female; 1069 male | |
| Kiadaliri, 2016 [ | Sweden | Population based cohort study | EQ-5D | 1501 | 744 | 402 | 71.5 | Group 1 (reference group having neither knee pain nor radiographic or clinically-defined knee OA) 469 female; 275 male |
| Group 2 (knee pain with-out OA) 119 female; 50 male | ||||||||
| Group 3 (kne epain with OA) 256 female; 146 male | ||||||||
| Kiadaliri, 2016 [ | Sweden | Retrospective | EQ-5D | First stage 7402; Second stage 1527 | The number of people diagnosis with knee OA is not specified | 69.4 | First stage 4604 female; 2798 male | |
| Second stage 977 female; 550 male | ||||||||
| Oishi, 2016 [ | Japan | Cross-Sectional | KOOS | 963 | 397 | 54.33 | Total: 595 female; 368 male | |
| Knee OA: 299 female; 98 male | ||||||||
| Sarumathy, 2016 [ | India | Prospective study | SF-36 | 74 | 74 | 51.7 | Knee OA: 55 female; 19 male | |
| Cavalcante, 2015 [ | Brazil | Cross-Sectional | WHOQOL | 90 | 40 | 50 | 67 | All female |
| Fang, 2015 [ | Taiwan | Population based study | SF-12 | 901 | 441 | 460 | 74.04 | Total: 492 female; 409 male |
| Knee OA: 232 female; 209 male | ||||||||
| Ferreira, 2015 [ | Brazil | Cross-Sectional | SF-36 | 75 | 35 | 40 | 68.36 | All female |
| Kawano, 2015 [ | Brazil | Cross-Sectional | SF-36 | 93 | 93 | 61.2 | Knee OA: 69 females; 24 male | |
| Kim, 2015 [ | Korea | Cross-Sectional | EQ-5D | 2165 | 2165 | 67.73 | Knee OA: 1458 female; 707 male | |
| Lee, 2015 [ | South Korea | Cross-Sectional | EQ-5D | 7977 | 7977 | 61.5 | Knee OA: 5448 female; 4064 male | |
| Pang, 2015 [ | China | Cross-Sectional | SF-36 | 466 | 466 | 56.56 | Knee OA: 382 female; 84 male | |
| Rakel, 2015 [ | USA | Cross-Sectional | SF-36 | 100 | 25 | 75 | 56 | Knee OA: 46 female; 29 male |
| Control: 15 female; 10 male | ||||||||
| Reid, 2015 [ | USA | Randomized controlled trial | SF-36 | 190 | 190 | 60.2 | Knee OA: 132 female; 58 male | |
| Tsonga, 2015 [ | Greece | Longitudinal | SF-36 | 68 | 68 | 73 | Knee OA: 57 female; 11 male | |
| Visser, 2015 [ | Netherlands | Cross-Sectional | SF-36 | 1262 | 1060 | 205 | 56 | Total: 707 female; 578 male |
| Knee OA: 125 female; 80 male | ||||||||
| Control: 583 female; 477 male | ||||||||
| Alburquerque-garcía, 2015 [ | Spain | Cross-Sectional | SF-36 | 36 | 18 | 18 | 85 | All female |
| Alkan, 2014 [ | Turkey | Cross-Sectional | SF-36 | 152 | 40 | 112 | 60 | Knee OA: 85 female; 27 male |
| Control: 30 female 10 male | ||||||||
| Forkel, 2014 [ | Germany | Cross-Sectional | KOOS | 22 | 22 | 47 | Knee OA: 17 female; 6 male | |
| Jahnke, 2014 [ | Germany | Cross-Sectional | HAS | 159 | 159 | 63.5 | Knee OA: 75 female; 84 male | |
| Marks, 2014 [ | USA | Cross-Sectional | AIMS | 21 | 21 | 70.8 | All female | |
| Pérez-Prieto, 2014 [ | Spain | Prospective cohort study | SF-36 | 716 | 716 | 72 | Knee OA: 421 female; 295 male | |
| Reis, 2014 [ | Brazil | Cross-Sectional | WHOQOL | 12 | 12 | 67.25 | All female | |
| Alentorn, 2013 [ | Spain | Cross-Sectional | SF-36 | 391 | 391 | 70.7 | Knee OA: 303 female; 89 male | |
| Clement, 2013 [ | UK | Cross-Sectional | SF-12 | 996 | 996 | 70.32 | Knee OA: 545 female; 421 male | |
| Vulcano, 2013 [ | USA | Prospective cohort study | SF-36 | 4732 | 4732 | 66.88 | Knee OA: 2881 female; 1851 male | |
| Williams, 2013 [ | UK | Cross-Sectional | EQ-5D | 2456 | 2456 | 71.4 | Knee OA: 1494 female; 962 male | |
| Coleman, 2012 [ | Australia | Cross-Sectional | SF-36 | 146 | 146 | 65 | Knee OA: 109 female; 37 male | |
| Gonçalves, 2012 [ | Portugal | Cross-Sectional | SF-36 | 136 | 136 | 67.2 | Knee OA: 94 female; 42 male | |
| Lim, 2012 [ | Philippine | Cross-Sectional | WOMAC | 90 | 70.14 | Knee OA: 68 female; 22 male | ||
| Elbaz, 2011 [ | Israel | Cross-Sectional | SF-36 | 1487 | 1487 | 61.9 | Knee OA: 950 female; 537 male | |
| Gonçalves, 2011 [ | Portugal | Cross-Sectional | KOOS | 377 | 377 | 67.8 | Knee OA: 282 females; 95 males | |
| Norimatsu, 2011 [ | Japan | Prospective population-based cohort study | Japanese Knee Osteoarthritis Measure (JKOM) | 333 | 333 | 64.2 | All female | |
| Ozcakir, 2011 [ | Turkey | Cross-Sectional | NHP | 100 | 100 | 59.5 | Knee OA: 83 female; 17 male | |
| Paker, 2011 [ | Turkey | Cross-Sectional | SF-36 | 75 | 75 | 66.1 | All female | |
| Foroughi, 2010 [ | Australia | Cross-Sectional | SF-36 | 17 | 17 | 66 | All female | |
| Jenkins, 2010 [ | USA | Cross-Sectional | QLI-A | 75 | 75 | 69 | Knee OA: 57 female; 18 male | |
| Kim, 2010 [ | Korea | Prospective cohort study | WOMAC | 504 | 504 | 70.2 | Knee OA: 274 female; 230 male | |
| Muraki, 2010 [ | Japan | Cross-Sectional | SF-8 | 2126 | 2126 | 68.9 | Knee OA: 1359 female; 767 male | |
| Watanabe, 2010 [ | Japan | Cross-Sectional | Japanese Knee Osteoarthritis Measure (JKOM) | 18 | 18 | 67 | All female | |
| Yildiz, 2010 [ | Turkey | Cross-Sectional | NHP | 140 | 140 | 59.39 | Knee OA: 104 females; 36 males | |
| Debi, 2009 [ | Israel | Cross-Sectional | SF-36 | 134 | 66.95 | Knee OA: 85 females; 49 males | ||
| Imamura, 2008 [ | Brazil | Cross-Sectional | SF-36 | 84 | 22 | 62 | 71.1 | All female |
| Control 68.95 | ||||||||
| Liikavainio, 2008 [ | Finland | Cross-Sectional | RAND-36 | 107 | 53 | 54 | 59 | All male |
| Control 59.24 | ||||||||
| Wang, 2008 [ | Germany | Cross-Sectional | SF-36 | 1009 | 1009 | 48.5 | Knee OA: 620 female; 389 male | |
| Nunez, 2007 [ | Spain | Cross-Sectional | SF-36 | 100 | 100 | 71.2 | Knee OA: 71 female; 29 male | |
| Salaffi, 2005 [ | Italy | Cross-Sectional | SF-36 | 264 | KneeOA 108 | 65.7 | Knee OA: 64 female; 44 male | |
| Knee OA + Hip OA 51 | Knee OA + Hip OA: 32 female; 19 male | |||||||
| Chacón, 2004 [ | Venezuela | Cross-Sectional | AIMS | 126 | 126 | 64 | Knee OA: 106 female; 20 male | |
| Lam, 2000 [ | China | Cross-Sectional case–control study | COOP/WONCA | 760 | 760 | 57.6 | Knee OA: 538 female; 222 male | |
| de Leeuw, 1998 [ | UK | Prospective trial | Rosser Index Matrix | 101 | 101 | 71.5 | Knee OA: 62 female; 39 male | |
| Donnell, 1998 [ | France | Cross-Sectional | Rosser Index Matrix | 221 | 221 | No specified | Knee OA: 174 female; 47 male | |
| Ries, 1995 [ | USA | Cross-Sectional | AIMS | 47 | 47 | 69.2 | Knee OA: 44 female; 3 male |
SF-36/SF-12/SF-8 (n=34); EQ-5D (n=6); KOOS (n=3); AIMS(n=3); WOMAC(n=3); Rossser Index matrix (n=2); NHP (n=2);JKOM(n=2); WHOQOL(n=2);COOP/WONCA (n=1); HAS(n=1); RAND-36(n=1)
aNot possible to add this article in gender calculation